Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy

被引：28

作者：

Danko, Janine R. ^{[1
]}

Gilliland, William R. ^{[2
]}

Miller, R. Scott ^{[3
]}

Decker, Catherine F. ^{[4
]}

机构：

[1] USN, Infect Dis Directorate, Viral Rickettsial Dis Dept, Med Res Ctr, Silver Spring, MD 20910 USA

[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA

[3] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA

[4] Natl Naval Med Ctr, Div Infect Dis, Bethesda, MD USA

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2009年 / 41卷 / 04期

关键词：

SKIN INFECTIONS;

D O I：

10.1080/00365540902774599

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Tumor necrosis factor- inhibitors are important adjunctive therapies for rheumatologic diseases. These agents increase the risk for granulomatous disease. We present a case of a woman with severe rheumatoid arthritis on infliximab who developed multiple nodular skin lesions. Biopsies grew Mycobacterium marinum. New lesions developed through therapy, necessitating surgical debulking.

引用

页码：252 / 255

页数：4

共 16 条

[1] MYCOBACTERIUM-MARINUM ARTHRITIS [J].

ALLOWAY, JA ;

EVANGELISTI, SM ;

SARTIN, JS .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 24 (06) :382-390

[2] Retrospective study of Mycobacterium marinum skin infections [J].

Ang, P ;

Rattana-Apiromyakij, N ;

Goh, CL .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (05) :343-347

[3] Sixty-three cases of Mycobacterium marinum infection -: Clinical features, treatment, and antibiotic susceptibility of causative isolates [J].

Aubry, A ;

Chosidow, O ;

Caumes, E ;

Robert, J ;

Cambau, E .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) :1746-1752

[4] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].

Bongartz, T ;

Sutton, AJ ;

Sweeting, MJ ;

Buchan, I ;

Matteson, EL ;

Montori, V .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285

[5] MYCOBACTERIUM-MARINUM INFECTIONS - A PROBLEM OF RECOGNITION, NOT THERAPY [J].

BROWN, JW ;

SANDERS, CV .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (05) :817-818

[6]

Casal M, 2001, INT J TUBERC LUNG D, V5, P197

[7] Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register [J].

Dixon, W. G. ;

Watson, K. ;

Lunt, M. ;

Hyrich, K. L. ;

Silman, A. J. ;

Symmons, D. P. M. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2368-2376

[8] MYCOBACTERIUM-MARINUM SKIN INFECTIONS - REPORT OF 31 CASES AND REVIEW OF THE LITERATURE [J].

EDELSTEIN, H .

ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (12) :1359-1364

[9]

ENZENAUER RJ, 1990, SOUTHERN MED J, V83, P471

[10] Disseminated cutaneous Mycobacterium marinum infection in a patient with non-Hodgkin's lymphoma [J].

Enzensberger, R ;

Hunfeld, KP ;

Elshorst-Schmidt, T ;

Böer, A ;

Brade, V .

INFECTION, 2002, 30 (06) :393-395

← 1 2 →